Thoracic Catheters Market Demand, Trends & Forecast by 2034

Coverage: By Indication (Type 2 diabetes, Obesity, C. Difficile Infection, Primary Hyperoxyurea, Crohn's Disease, Inflammatory Bowel Diseases, Ulcerative Colitis); End User (Hospital, Clinics, Ambulatory Surgery Center, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00027705
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : May 26, 2026
Thoracic Catheters Market Demand, Trends & Forecast by 2034
Report Date: May 26, 2026   |   Report Code: TIPRE00027705 Email: sales@theinsightpartners.com

2025 Market Size

US$ 550.15 Mn

Base year value

2034 Forecast

US$ 892.4 Mn

Projected by 2034

CAGR 2026-2034

6.23 %

Growth rate

Addressable Market

US$ 6,780.07 Mn

(2026-2034)

The Thoracic Catheters Market size is expected to reach US$ 892.4 Million by 2034 from US$ 550.15 Million in 2025. The market is estimated to record a CAGR of 6.23% from 2026 to 2034.

MARKET OVERVIEW


Prostate-specific antigen, also known as gamma-seminoprotein or kallikrein-3, P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland.


MARKET SCOPE


The "Global PSA Test Market Analysis to 2034" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the PSA Test market with detailed market segmentation by test type and assay type. The report provides key statistics on the market status of the leading PSA Test market players and offers key trends and opportunities in the market.


Market Assessment and Insights

  • Global market for Thoracic Catheters was valued at US$ 550.15 Million in 2025
  • Annual market size is expected to reach US$ 892.40 Million by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 6,780.07 Million
  • Market is anticipated to register a CAGR of 6.23% during the forecast period
  • The United States represents a key market, supported by Rising Cases of Minimally Invasive Surgeries, Rising cases of respiratory disorders, Reimbursement Policies, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Vacuum Management, Rise in Patient Mobility, Point of care testing patterns are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Abbott Laboratories, Inc., Boston Scientific Corporation, Bayer AG, Bristol Myers Squibb Company, Beckman Coulter, Inc., GE Healthcare, Endocare, Inc., Merck and Co., Inc., Medtronic, Inc., Sanofi Aventis SA., while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Thoracic Catheters Market: Strategic Insights

thoracic-catheters-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MARKET SEGMENTATION



  1. Based on test type the market is segmented as, Total Prostate Specific Antigen Test (tPSA), Complex Prostate Specific Antigen Test (cPSA), Free Prostate Specific Antigen Test (fPSA), Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR), PCA3Test, Trans-rectal Ultrasound, Biopsy.
  2. Based on assay type the market is segmented as, Radioimmunoassay (RIA), Enzyme Immunoassay (EIA).

MARKET DYNAMICS


Drivers:



  1. Rising prevalence prostate disorders.
  2. Rising geriatric population.
  3. Extensive R&D efforts by pharmaceutical and biotechnological companies to develop novel therapies is expected to fuel the market growth.

Restraints:



  1. Whereas, high cost of treatment and test is expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2034 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South and Central America. The PSA Test market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.


The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South and Central America after evaluating political, economic, social and technological factors affecting the PSA Test market in these regions.


IMPACT OF COVID-19 ON PSA TEST MARKET


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products.


According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


MARKET PLAYERS


The report covers key developments in the PSA Test market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from PSA Test market are anticipated to lucrative growth opportunities in the future with the rising demand for PSA Test in the global market.


The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the PSA Test market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.



  1. ABBOTT LABORATORIES, INC.
  2. BOSTON SCIENTIFIC CORPORATION
  3. BAYER AG
  4. BRISTOL MYERS SQUIBB COMPANY
  5. BECKMAN COULTER, INC.
  6. GE HEALTHCARE
  7. ENDOCARE, INC.
  8. MERCK AND CO., INC.
  9. MEDTRONIC, INC.
  10. SANOFI AVENTIS SA.

Thoracic Catheters Market Report Scope

Report Attribute Details
Market size in 2025 US$ 550.15 Million
Market Size by 2034 US$ 892.4 Million
Global CAGR (2026 - 2034) 6.23%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Indication
  • Type 2 diabetes
  • Obesity
  • C. Difficile Infection
  • Primary Hyperoxyurea
  • Crohn's Disease
  • Inflammatory Bowel Diseases
  • Ulcerative Colitis
By End User
  • Hospital
  • Clinics
  • Ambulatory Surgery Center
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Bayer AG
  • Bristol Myers Squibb Company
  • Beckman Coulter, Inc.
  • GE Healthcare
  • Endocare, Inc.
  • Merck and Co., Inc.
  • Medtronic, Inc.
  • Sanofi Aventis SA.

Thoracic Catheters Market Players Density: Understanding Its Impact on Business Dynamics

The Thoracic Catheters Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

thoracic-catheters-market-cagr


Frequently Asked Questions

Vacuum Management

Risk of Increased Air Leakage

Europe region is expected to witness a high growth rate in terms of CAGR of 6.23% from 2026 to 2034

The Thoracic Catheters Market is estimated to witness a CAGR of 6.23% from 2026 to 2034

Rising incidence of minimally invasive surgeries

Asia Pacific region is expected to witness the highest growth during the forecast period
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA